Literature DB >> 23522175

Hypersomatotropism, acromegaly, and hyperadrenocorticism and feline diabetes mellitus.

Stijn J M Niessen1, David B Church, Yaiza Forcada.   

Abstract

When confronted with a diabetic cat in clinical practice, it is tempting to assume it has a form of diabetes mellitus akin to human type 2 diabetes mellitus (diabetes). For most diabetic cats examined, this will indeed be justified. Nevertheless, a significant proportion have other specific types of diabetes with distinctly different etiologies. This article discusses the concept of other specific types of feline diabetes caused by endocrinopathies, and more specifically feline hypersomatotropism, acromegaly, and hyperadrenocorticism, including relevance, presentation, diagnosis, and therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23522175     DOI: 10.1016/j.cvsm.2012.12.004

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  17 in total

1.  Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Authors:  Francesco Zublena; Alice Tamborini; Carmel T Mooney; Susan M North; Monika A Lobacz; Dan Andrew; Vanessa Woolhead; Heather Covey; Herbert A Schmid; David B Church; Stijn J M Niessen
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.

Authors:  Stijn J M Niessen; Yaiza Forcada; Panagiotis Mantis; Christopher R Lamb; Norelene Harrington; Rob Fowkes; Márta Korbonits; Ken Smith; David B Church
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

3.  Glycemic status and predictors of relapse for diabetic cats in remission.

Authors:  S Gottlieb; J S Rand; R Marshall; J Morton
Journal:  J Vet Intern Med       Date:  2014-11-24       Impact factor: 3.333

4.  Pasireotide for the Medical Management of Feline Hypersomatotropism.

Authors:  C J Scudder; R Gostelow; Y Forcada; H A Schmid; D Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

5.  Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.

Authors:  K B Jensen; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

6.  Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.

Authors:  R Gostelow; C Scudder; S Keyte; Y Forcada; R C Fowkes; H A Schmid; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2017-02-01       Impact factor: 3.333

7.  Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.

Authors:  Kieran Borgeat; Stijn J M Niessen; Lois Wilkie; Norelene Harrington; David B Church; Virginia Luis Fuentes; David J Connolly
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.

Authors:  J M Fletcher; C J Scudder; M Kiupel; H N Pipe-Martin; P J Kenny; P Mantis; J Fenn; K Smith; R V Blair; L A Granger; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-06-03       Impact factor: 3.333

Review 9.  What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.

Authors:  C Gilor; S J M Niessen; E Furrow; S P DiBartola
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

10.  Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.

Authors:  S V Keyte; P J Kenny; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.